0001562180-20-003210.txt : 20200429
0001562180-20-003210.hdr.sgml : 20200429
20200429202048
ACCESSION NUMBER: 0001562180-20-003210
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200427
FILED AS OF DATE: 20200429
DATE AS OF CHANGE: 20200429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSMITH MARK A
CENTRAL INDEX KEY: 0001246842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 20832699
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001434418
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-714-0555
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-04-27
false
0001434418
CONSTELLATION PHARMACEUTICALS INC
CNST
0001246842
GOLDSMITH MARK A
C/O CONSTELLATION PHARMACEUTICALS, INC.
215 FIRST STREET, SUITE 200
CAMBRIDGE
MA
02142
true
false
true
false
Common Stock
2020-04-27
4
M
false
400.00
1.55
A
143463.00
I
Owned by Trusts for which Mark A. Goldsmith is a Trustee
Common Stock
2020-04-27
4
S
false
400.00
40.1225
D
143063.00
I
Owned by Trusts for which Mark A. Goldsmith is a Trustee
Stock Option (Right to Buy)
1.55
2020-04-27
4
M
false
400.00
0.00
D
2021-03-10
Common Stock
400.00
26850.00
D
These trades were made pursuant to a Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $40.03 to $40.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares are fully vested.
/s/ Emma Reeve, as Attorney-in-Fact for Mark A. Goldsmith
2020-04-29